The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Lumirelax     [2-hydroxy-3-(2- methoxyphenoxy)propyl]...

Synonyms: Etroflex, Forbaxin, Methocal, Miorilas, Neuraxin, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of methocarbamol


Psychiatry related information on methocarbamol


High impact information on methocarbamol


Biological context of methocarbamol


Anatomical context of methocarbamol


Associations of methocarbamol with other chemical compounds


Gene context of methocarbamol


Analytical, diagnostic and therapeutic context of methocarbamol

  • Sequence analysis identified a novel type of neuron-specific protein (named neuraxin) which is characterized by an unusual amino acid composition, 12 central heptadecarepeats and putative protein and/or membrane interaction sites [6].
  • Significant increases in plasma hemoglobin were detected 30 min after intravenous injection of methocarbamol or its vehicle alone [17].
  • A new HPLC technique for the separation of methocarbamol enantiomers [18].
  • We have developed a stereoselective high-performance liquid chromatography technique for analytical separation of methocarbamol enantiomers [18].
  • 1. Permethylation and g.l.c.-mass spectrometric analysis of bile from an isolated rat liver perfusion to which methocarmol was added showed seven components not present in control bile: methocarbamol, glucuronides of methocarbamol and desmethyl-methocarbamol, and four glucuronides of hydroxylated methocarbamol metabolites [19].


  1. Intravenous methocarbamol in the treatment of stiff-man syndrome. Voci, J.M., al-Hakim, M., Dokko, Y., Katirji, M.B. Muscle Nerve (1993) [Pubmed]
  2. A double-blind trial of methocarbamol versus placebo in painful muscle spasm. Valtonen, E.J. Current medical research and opinion. (1975) [Pubmed]
  3. Pharmacokinetics and protein binding of methocarbamol in renal insufficiency and normals. Sica, D.A., Comstock, T.J., Davis, J., Manning, L., Powell, R., Melikian, A., Wright, G. Eur. J. Clin. Pharmacol. (1990) [Pubmed]
  4. Therapeutic trial of methocarbamol (Robinax) in tetanus neonatorum. Lall, J.C., Gupta, H.L. Indian pediatrics. (1975) [Pubmed]
  5. Subjective and behavioral effects of diphenhydramine, lorazepam and methocarbamol: evaluation of abuse liability. Preston, K.L., Wolf, B., Guarino, J.J., Griffiths, R.R. J. Pharmacol. Exp. Ther. (1992) [Pubmed]
  6. Neuraxin, a novel putative structural protein of the rat central nervous system that is immunologically related to microtubule-associated protein 5. Rienitz, A., Grenningloh, G., Hermans-Borgmeyer, I., Kirsch, J., Littauer, U.Z., Prior, P., Gundelfinger, E.D., Schmitt, B., Betz, H. EMBO J. (1989) [Pubmed]
  7. Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1. Dgany, O., Avidan, N., Delaunay, J., Krasnov, T., Shalmon, L., Shalev, H., Eidelitz-Markus, T., Kapelushnik, J., Cattan, D., Pariente, A., Tulliez, M., Crétien, A., Schischmanoff, P.O., Iolascon, A., Fibach, E., Koren, A., Rössler, J., Le Merrer, M., Yaniv, I., Zaizov, R., Ben-Asher, E., Olender, T., Lancet, D., Beckmann, J.S., Tamary, H. Am. J. Hum. Genet. (2002) [Pubmed]
  8. Inhibition of carbonic anhydrases I and II by N-unsubstituted carbamate esters. Parr, J.S., Khalifah, R.G. J. Biol. Chem. (1992) [Pubmed]
  9. Neuraxin corresponds to a C-terminal fragment of microtubule-associated protein 5 (MAP5). Kirsch, J., Littauer, U.Z., Schmitt, B., Prior, P., Thomas, L., Betz, H. FEBS Lett. (1990) [Pubmed]
  10. High-performance liquid chromatographic analysis of methocarbamol enantiomers in biological fluids. Alessi-Severini, S., Coutts, R.T., Jamali, F., Pasutto, F.M. J. Chromatogr. (1992) [Pubmed]
  11. Methocarbamol degradation in aqueous solution. Pouli, N., Antoniadou-Vyzas, A., Foscolos, G.B. Journal of pharmaceutical sciences. (1994) [Pubmed]
  12. Parafon Forte versus Robaxisal in skeletal muscle disorders: a double-blind study. Gready, D.M. Current therapeutic research, clinical and experimental. (1976) [Pubmed]
  13. A comparison of calcium gluconate and methocarbamol (Robaxin) in the treatment of Latrodectism (black widow spider envenomation). Key, G.F. Am. J. Trop. Med. Hyg. (1981) [Pubmed]
  14. Muscle relaxant activity of methocarbamol enantiomers in mice. Souri, E., Sharifzadeh, M., Farsam, H., Gharavi, N. J. Pharm. Pharmacol. (1999) [Pubmed]
  15. Simultaneous determination of paracetamol and methocarbamol in tablets by ratio spectra derivative spectrophotometry and LC. Erk, N., Ozkan, Y., Banoğlu, E., Ozkan, S.A., Sentürk, Z. Journal of pharmaceutical and biomedical analysis. (2001) [Pubmed]
  16. Reduced hospitalization cost for patients with pectus excavatum treated using minimally invasive surgery. Inge, T.H., Owings, E., Blewett, C.J., Baldwin, C.E., Cain, W.S., Hardin, W., Georgeson, K.E. Surgical endoscopy. (2003) [Pubmed]
  17. Hemolytic potential of methocarbamol. Scott, R.B., Tisdale, S.A., Cummings, W.B. Clin. Pharmacol. Ther. (1977) [Pubmed]
  18. A new HPLC technique for the separation of methocarbamol enantiomers. Farsam, H., Souri, E., Gharavi, N. J. Pharm. Pharmacol. (1999) [Pubmed]
  19. Metabolism of methocarbamol (robaxin) in the isolated perfused rat liver and identification of glucuronides. Thompson, R.M., Gerber, N., Seibert, R.A. Xenobiotica (1975) [Pubmed]
WikiGenes - Universities